1. Volume 28, Issue 12, Pages 790-796 (December 2016)
Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer 
R. Leibowitz-Amit, A. Israel, M. Gal, E.A. Atenafu, Z. Symon, O. Portnoy, M. Laufer, Z. Dotan, J. Ramon, D. Avni, E. Fridman, R. Berger 
Clinical Oncology 
Volume 28, Issue 12, Pages (December 2016)
DOI: /j.clon
Copyright © 2016 The Royal College of Radiologists Terms and Conditions

2. Fig 1 Patient treatment allocation.
Clinical Oncology  , DOI: ( /j.clon )
Copyright © 2016 The Royal College of Radiologists Terms and Conditions

3. Fig 2
Overall survival curves of 'responders' and 'non-responders'. Survival in patients who achieved a pathological complete response (dotted red line) or did not achieve a pathological complete response (blue line) was calculated using the Kaplan–Meier analysis and compared using the Log-rank test.
Clinical Oncology  , DOI: ( /j.clon )
Copyright © 2016 The Royal College of Radiologists Terms and Conditions

4. Fig 3
Time trend of laboratory variables in 'responders' and 'non-responders'. The mean value at three time points (pre-neoadjuvant chemotherapy, pre-surgery and post-surgery) are shown with lines (blue: non-responders; red: responders), whereas individual values are depicted in dots.
Clinical Oncology  , DOI: ( /j.clon )
Copyright © 2016 The Royal College of Radiologists Terms and Conditions